Rapid Assessment of Susceptibility of Bacteria and Erythrocytes to Antimicrobial Peptides by Single-Cell Impedance Cytometry

• Published in: ACS sensors Vol. 8; no. 7; pp. 2572 - 2582
• Main Authors: Troiano, Cassandra, De Ninno, Adele, Casciaro, Bruno, Riccitelli, Francesco, Park, Yoonkyung, Businaro, Luca, Massoud, Renato, Mangoni, Maria Luisa, Bisegna, Paolo, Stella, Lorenzo, Caselli, Federica
• Format: Journal Article
• Language: English
• Published: United States American Chemical Society 28.07.2023
• Subjects: Antimicrobial Cationic Peptides - chemistry; Antimicrobial Cationic Peptides - pharmacology; Antimicrobial Peptides; Bacteria; Electric Impedance; Erythrocytes; Humans; electrical sensing; antimicrobial peptides (AMPs); antimicrobial susceptibility testing (AST); microfluidic impedance cytometry; Bacillus megaterium; single-cell analysis; erythrocyte
• ISSN: 2379-3694; 2379-3694
• DOI: 10.1021/acssensors.3c00256

Antimicrobial peptides (AMPs) represent a promising class of compounds to fight antibiotic-resistant infections. In most cases, they kill bacteria by making their membrane permeable and therefore exhibit low propensity to induce bacterial resistance. In addition, they are often selective, killing bacteria at concentrations lower than those at which they are toxic to the host. However, clinical applications of AMPs are hindered by a limited understanding of their interactions with bacteria and human cells. Standard susceptibility testing methods are based on the analysis of the growth of a bacterial population and therefore require several hours. Moreover, different assays are required to assess the toxicity to host cells. In this work, we propose the use of microfluidic impedance cytometry to explore the action of AMPs on both bacteria and host cells in a rapid manner and with single-cell resolution. Impedance measurements are particularly well-suited to detect the effects of AMPs on bacteria, due to the fact that the mechanism of action involves perturbation of the permeability of cell membranes. We show that the electrical signatures of Bacillus megaterium cells and human red blood cells (RBCs) reflect the action of a representative antimicrobial peptide, DNS-PMAP23. In particular, the impedance phase at high frequency (e.g., 11 or 20 MHz) is a reliable label-free metric for monitoring DNS-PMAP23 bactericidal activity and toxicity to RBCs. The impedance-based characterization is validated by comparison with standard antibacterial activity assays and absorbance-based hemolytic activity assays. Furthermore, we demonstrate the applicability of the technique to a mixed sample of B. megaterium cells and RBCs, which paves the way to study AMP selectivity for bacterial versus eukaryotic cells in the presence of both cell types.